Aging Skeletal Muscles: What Are the Mechanisms of Age-Related Loss of Strength and Muscle Mass, and Can We Impede Its Development and Progression?
International Journal of Molecular Sciences · 11.10.2024 · 25 (20) · 10932
DOI: 10.3390/ijms252010932 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.10.2024. Verfasst von Thomas Gustafsson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden. Hauptthemen laut MEDLINE: Sarcopenia, Muscle, Skeletal, Aging, Muscle Strength. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet and the National research council (VR), Karolinska Institutet, National research council.
Abstract (Originalsprache)
As we age, we lose muscle strength and power, a condition commonly referred to as sarcopenia (ICD-10-CM code (M62.84)). The prevalence of sarcopenia is about 5–10% of the elderly population, resulting in varying degrees of disability. In this review we emphasise that sarcopenia does not occur suddenly. It is an aging-induced deterioration that occurs over time and is only recognised as a disease when it manifests clinically in the 6th–7th decade of life. Evidence from animal studies, elite athletes and longitudinal population studies all confirms that the underlying process has been ongoing for decades once sarcopenia has manifested. We present hypotheses about the mechanism(s) underlying this process and their supporting evidence. We briefly review various proposals to impede sarcopenia, including cell therapy, reducing senescent cells and their secretome, utilising targets revealed by the skeletal muscle secretome, and muscle innervation. We conclude that although there are potential candidates and ongoing preclinical and clinical trials with drug treatments, the only evidence-based intervention today for humans is exercise. We present different exercise programmes and discuss to what extent the interindividual susceptibility to developing sarcopenia is due to our genetic predisposition or lifestyle factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
ORCID-Profile: Brun Ulfhake
Förderung
- Karolinska Institutet and the National research council (VR)
- Karolinska Institutet
- National research council
Zitieren
APA
Gustafsson, T., & Ulfhake, B. (2024). Aging Skeletal Muscles: What Are the Mechanisms of Age-Related Loss of Strength and Muscle Mass, and Can We Impede Its Development and Progression?. International Journal of Molecular Sciences, 25(20), 10932. https://doi.org/10.3390/ijms252010932
Vancouver
Gustafsson T, Ulfhake B. Aging Skeletal Muscles: What Are the Mechanisms of Age-Related Loss of Strength and Muscle Mass, and Can We Impede Its Development and Progression?. International Journal of Molecular Sciences. 2024;25(20):10932. doi:10.3390/ijms252010932
BibTeX
@article{Gustafsson2024,
author = {Gustafsson, Thomas and Ulfhake, Brun},
title = {Aging Skeletal Muscles: What Are the Mechanisms of Age-Related Loss of Strength and Muscle Mass, and Can We Impede Its Development and Progression?},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {20},
pages = {10932},
doi = {10.3390/ijms252010932}
}
EUVIMED